Med 20chem 20background
2 20color 20kineta 20logo 20  20new 20tagline

Kineta, Inc.

Kineta: An emerging biotech company that fills a void in the biotech industry by advancing first in class immuno-therapies from discovery to proof of concept.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Seattle, WA, USA
  • Currency USD
  • Founded January 2008
  • Employees 42
  • Incorporation Type C-corp
  • Website kinetabio.com

Company Summary

Kineta is an emerging biotech company that fills a void in the biopharmaceutical industry by efficiently advancing first in class immuno-therapies from discovery to proof of concept. Kineta is developing a focused pipeline of novel therapies that address critical unmet patient needs in the areas of oncology, chronic pain and biodefense.

Team

  • Default avatar
    Shawn Iadonato, PhD
    CEO

    Human Genome Project; Co-Founder of Illumigen Biosciences ($340M exit) and Kineta; Established and grew five Kineta drug programs; 1st Kv1.3 inhibitor in Clinic; Secured >$57M R&D funding grants

  • D0fdbc67 2383 44f2 ada0 c07eb704c8cb
    President and COO

    25+ years in the pharmaceutical industry; Corporate development at Kineta; Major Accounts, Managed Care & Sales/ Marketing at Pfizer and Amgen; National Director Schering–Plough

  • 9a426d1b b436 4dca 90b6 f8a1b25bc344
    SVP Business Development & Corp. Comm.

    25+ years in commercial operations in the pharmaceutical industry; marketing, payer strategy, pricing, national accounts, sales leadership and business development at GSK and Schering-Plough.

  • Default avatar
    Campion Fellin, MSE
    SVP Operations

    25+ years operations and program management experience; Software and Biotech Industries; Manages 10M+ in NIH Grant Awards, IT, accounting, and facilities management expertise.

  • Default avatar
    Pauline Kenny, JD
    General Counsel

    15+ years of legal experience in both in-house and outside counsel roles; general corporate matters, financing, licensing, intellectual property, M&A and other legal and strategic matters

  • Ken 20north 20  20web
    SVP Corporate Development

    40 years of banking and fund raising experience. Corporate Development at Kineta; Founding CEO Seattle Savings Bank; Past president Seattle Kiwanis, Chamber of Commerce, Seafair Commodores

  • 490ebd49 75d6 4255 9879 1a574053f0dc
    VP Translational Development

    15+ years of experience in immunology/infectious disease research and translational drug development; founding scientist at Kineta; leads strategy and development for nonclinical, clinical, and CMC

  • Default avatar
    Kristin Bedard, PhD
    VP Research & Development

    15+ years of experience in virology and drug development; founding scientist at Kineta; established AViid™ screening platform; 15 US patent applications; awarded 7 NIH grants and contracts

Advisors

  • Default avatar
    Moss Adams
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Iacocca Family Foundation
    Unconfirmed
    Default avatar
    Ray and Lydia Bartoszek
    Unconfirmed
    Default avatar
    Individuals
    Unconfirmed